Skip to main content
John Letterio, MD, Pediatric Hematology & Oncology, Cleveland, OH, University Hospitals Cleveland Medical Center

JohnJLetterioMD

Pediatric Hematology & Oncology Cleveland, OH

Professor, Pediatrics, Case Western Reserve University School of Medicine

Dr. Letterio is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Letterio's full profile

Already have an account?

  • Office

    UH Rainbow Babies and Children's Hospital
    11100 Euclid Ave Department of Pediatrics-Hematology and Oncology
    Cleveland, OH 44106
    Phone+1 216-844-7700
    Fax+1 216-844-5431
  • Is this information wrong?

Education & Training

  • Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens Hospital
    Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 1987 - 1990
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 1987

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2007 - 2024
  • MD State Medical License
    MD State Medical License 1990 - 2008

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Publications & Presentations

PubMed

Abstracts/Posters

  • Preclinical Studies and Phase I Trial of Vactosertib in Combination with Pomalidomide in Relapsed Multiple Myeloma: A Corticosteroid-Free Approach By Targeting TGF-_ S...
    John Letterio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Vactosertib, a TGF-ß Receptor I Kinase/ALK5 Inhibitor, Diminishes Tumor Progression and Bone Disease in a Mouse Model of Multiple Myeloma and Overcomes Resistance to P... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Preclinical Studies and a Phase I Trial of the TGF-β Receptor Inhibitor, Vactosertib (TEW-7197), in Combination with Pomalidomide in Patients with Multiple Myeloma Ref... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • National Experts Map Out Adolescent and Young Adult (AYA) Cancer Research Agenda
    National Experts Map Out Adolescent and Young Adult (AYA) Cancer Research AgendaDecember 5th, 2017
  • St. Baldrick's Head Shaving for Cancer Research at Rainbow Babies & Children's Hospital
    St. Baldrick's Head Shaving for Cancer Research at Rainbow Babies & Children's HospitalMarch 10th, 2017
  • Colon Cancer in Millennials? Two Cleveland Area Women Warning Others About Rare Diagnosis
    Colon Cancer in Millennials? Two Cleveland Area Women Warning Others About Rare DiagnosisDecember 27th, 2016
  • Join now to see all

Grant Support

  • Discovery And Evaluation Of Novel Triterpenoid Chemopreventives In A New Colon CANational Cancer Institute2008–2009
  • Tgf-Beta1 In Hematopoietic And Immune Cell DifferentiatiDivision Of Basic Sciences - Nci2002–2004
  • Tgf-Beta1 In Hematopoietic &Immune Cell DifferentiationDivision Of Basic Sciences - Nci2003
  • Tgf-Beta1: Hematopoietic And Immune Cell DifferentiationDivision Of Basic Sciences - Nci2001
  • Tgf-Beta1 In Hematopoietic And Immune Cell Differentiation And FunctionDivision Of Basic Sciences - Nci1999–2000
  • TGF Beta In Hematopoietic And Immune Cell Differentiation And FunctionDivision Of Basic Sciences - Nci1996–1998

Hospital Affiliations